Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
5,27 USD | +7,11% | +12,13% | -40,52% |
Attività
Numero di dipendenti: 234
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 70 | 01/07/20 | |
Allan Reine
DFI | Director of Finance/CFO | 49 | 17/01 |
Chief Operating Officer | 52 | 01/09/22 | |
Jeremy Duffield
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/01/21 |
Ann Lee
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/10/21 |
Mohammed Asmal
CTO | Chief Tech/Sci/R&D Officer | - | - |
Fubao Wang
LAW | General Counsel | - | - |
Karen Brown
LAW | General Counsel | - | - |
Niamh Alix
HRO | Human Resources Officer | - | 01/06/22 |
Carman Alenson
AUD | Comptroller/Controller/Auditor | 58 | 01/08/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 64 | 01/12/21 | |
Robert Nelsen
BRD | Director/Board Member | 60 | 01/09/20 |
Michael Kelly
BRD | Director/Board Member | 67 | 01/11/21 |
David Schenkein
BRD | Director/Board Member | 66 | 13/09/19 |
Chief Executive Officer | 70 | 01/07/20 | |
Director/Board Member | 46 | 10/05/23 | |
Thomas Cahill
BRD | Director/Board Member | 37 | 01/11/21 |
Wendy Chung
BRD | Director/Board Member | 55 | 01/11/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 119 939 247 | 89 931 997 ( 74,98 %) | 0 | 74,98 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-40,52% | 608 Mln | |
-1,17% | 104 Mrd | |
+2,87% | 97,47 Mrd | |
+4,31% | 22,25 Mrd | |
-14,77% | 21,68 Mrd | |
-9,19% | 18,2 Mrd | |
-39,98% | 17,02 Mrd | |
-13,21% | 16,36 Mrd | |
+8,55% | 14,39 Mrd | |
+35,75% | 12,37 Mrd |
- Borsa valori
- Azioni
- Azione PRME
- Società Prime Medicine, Inc.